U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07393451) titled 'A Multicenter Phase 2a Clinical Study to Evaluate SIM0278 in Subjects With Active Lupus Nephritis' on Jan. 30.
Brief Summary: This is a randomized, double-blind, placebo-controlled multicenter clinical study to evaluate the efficacy, safety, and pharmacokinetics of SIM0278 in adult (18-75 years) subjects with active LN suitable for systemic therapy.
Approximately 60 subjects with active LN are planned to be enrolled and randomized 1: 1 to SIM0278 or placebo.
The study consists of 3 phases: screening, double-blind treatment, and safety follow-up.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Lupus Nephritis
I...